ILESX | RGAGX | ILESX / RGAGX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 4 years | 15 years | - |
Gain YTD | 18.913 | 19.586 | 97% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 295K | 290B | 0% |
Annual Yield % from dividends | 1.09 | 0.75 | 146% |
Returns for 1 year | 24.60 | 24.16 | 102% |
Returns for 3 years | 18.83 | -2.53 | -744% |
Returns for 5 years | N/A | 52.01 | - |
Returns for 10 years | N/A | 64.63 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNIX | 81.37 | -0.15 | -0.18% |
Janus Henderson Global Life Sciences I | |||
NUEIX | 20.43 | -0.04 | -0.20% |
Northern US Quality ESG I | |||
PGRRX | 44.32 | -0.10 | -0.23% |
Pioneer Select Mid Cap Growth R | |||
FIFQX | 21.15 | -0.07 | -0.33% |
Fidelity Founders C | |||
BIDEX | 10.24 | -0.05 | -0.49% |
BlackRock Defensive Advantage EM Instl |